# reload+after+2024-01-23 12:43:09.886744
address1§465 State Route 17
city§Ramsey
state§NJ
zip§07446
country§United States
phone§201 478 5552
fax§201 478 5553
website§https://www.admabiologics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
fullTimeEmployees§617
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Adam S. Grossman', 'age': 46, 'title': 'Co-Founder, President, CEO & Director', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 1519436, 'exercisedValue': 0, 'unexercisedValue': 1439367}, {'maxAge': 1, 'name': 'Dr. Jerrold B. Grossman D.P.S., Ph.D.', 'age': 75, 'title': 'Co-Founder & Vice Chairman of the Board', 'yearBorn': 1948, 'fiscalYear': 2022, 'totalPay': 80000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brian  Lenz CPA', 'age': 51, 'title': 'Executive VP, CFO & GM of ADMA BioCenters', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 1083118, 'exercisedValue': 0, 'unexercisedValue': 556033}, {'maxAge': 1, 'name': 'Ms. Kaitlin  Kestenberg', 'title': 'Senior Vice President of Compliance & Project Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Drew  Pantello', 'title': 'Vice President of Marketing & Corporate Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Neal C. Fitzpatrick', 'title': 'Vice President of Sales', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Cindy  Petersen', 'title': 'Executive Director of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Skyler  Bloom', 'title': 'Senior Director of Business Development & Corporate Strategy', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§7
compensationRisk§7
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.543
priceToSalesTrailing12Months§4.2436614
currency§USD
dateShortInterest§1702598400
forwardEps§0.17
exchange§NGM
quoteType§EQUITY
shortName§ADMA Biologics Inc
longName§ADMA Biologics, Inc.
firstTradeDateEpochUtc§1382016600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§98c34fdf-5e27-3b32-9f32-8b49c01ae8aa
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§5.0
targetMeanPrice§6.0
targetMedianPrice§6.0
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§2.521
grossMargins§0.31641
ebitdaMargins§0.0525
trailingPegRatio§None
